SF05030MB: Cordis Smart Flex Biliary Stent System: 5mm x 30mm x 120cm

Sign in to add this product to your favorites!
| Price: | $249.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Status: | expired |
Additional Details
Cordis S.M.A.R.T.® Flex Biliary Stent
- Built upon the PALMAZ® Stent heritage with a tissue-to-metal ratio of 80% to 90% and high radial strength
- Easy, accurate placement due to low deployment forces and fully connected architecture
- Optimal, closed-cell scaffolding with uniform coverage
- Type: Fully connected yet flexible design
- Material: Nitinol with tantalum markers on stent ends
- Maximum Guidewire: 0.035"
- Sheath compatibility: 6F
AccessGUDID Info
- FDA Product Code: NIP
- FDA Product Code Name: Stent, Superficial Femoral Artery
- GMDN Term Code: 43691
- GMDN Term Name: Bare-metal biliary stent
- GMDN Term Description: A non-bioabsorbable tubular device intended to be implanted in an obstructed biliary duct (e.g., common bile duct) to maintain luminal patency; it is not intended for vascular implantation. It may be a mesh structure or a continuous tube and is made entirely of metal [e.g., high-grade stainless steel, cobalt-chrome (Co-Cr), nickel-titanium alloy (Nitinol)]. It may be expandable in situ (e.g., with a balloon catheter or self-expands) and disposable devices intended to assist implantation may be included.
Manufacturer
Cordis is a global leader in interventional cardiovascular technologies, with a strong legacy in developing minimally invasive solutions for the treatment of coronary and peripheral vascular disease. Their portfolio includes diagnostic and interventional catheters, guidewires, and balloon angioplasty systems, as well as stents like the SMART Control and S.M.A.R.T. Flex for peripheral use. Cordis also offers radial access products and closure devices to support efficient and safe procedures. With a renewed focus on innovation and global expansion, Cordis continues to provide trusted tools that help physicians deliver effective, streamlined care in both coronary and endovascular interventions.
IN-DATE